The M Welborn Group, LLC is a limited liability corporation that provides consultant services to pharmaceutical companies who are seeking to obtain Orphan or New Drug approval including drug application, IND submission and facilitation through the US Food and Drug Administration. Our mission is to facilitate approval of products focussing on rare diseases, in a timely and strategic manner, and to provide education for specialists who prescribe these drugs beginning in the early approval process and carrying through to drug approval and launch.

Integrity Transparency Advocacy Sense of Urgency Excellence Solidarity